about
Maternal mortality due to hypertensive disorders in pregnancy, childbirth, and the puerperium between 2012 and 2015 in Turkey: A nation-based study.The effect of resveratrol on blood pressure in a rat model of preeclampsia.Comparison of serum maternal adiponectin concentrations in women with isolated intrauterine growth retardation and intrauterine growth retardation concomitant with pre-eclampsia.Evaluation of bone density measurement in type 2 diabetic postmenopausal women with hypertension and hyperlipidemia.Factors Associated with Mammographic Density in Postmenopausal Women.Postmenopausal Osteoporosis Is Associated with Serum Chemerin and Irisin but Not with Apolipoprotein M Levels.Role of Oxidative Stress on Vaginal Bleeding during The First Trimester of Pregnant Women.Effect of the afterloaded external guidance embryo transfer technique on pregnancy rates in single embryo transfer cycles.The effect of Ramadan fasting on sirtuin and visfatin levels.Can maternal serum C-reactive protein levels predict successful labour induction with intravenous oxytocin in term pregnancies complicated with premature rupture of the membranes? A cross-sectional study.Association of Helicobacter pylori infection with systemic inflammation in preeclampsia.Does ovulation induction and intrauterine insemination affect perinatal outcomes in singletons?Is there any relationship between serum sirtuin-1 level and neutrophil-lymphocyte ratio in hyperemesis gravidarum?Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.The impact of single embryo transfer policy on pregnancy outcomes after legislative change.Comparison of C-reactive protein levels in pregnancies with retained and removed intrauterine device.Maternal mortality cases from pulmonary embolism: A nation-wide study in Turkey.Short-term effect of tibolone on C-reactive protein in hypertensive postmenopausal women.Effect of intranasal estrogen on vocal quality.The effect of resveratrol on prevention of the development of postoperative adhesions in a rat model.Body Mass Index Effects Kruger's Criteria in Infertile Men.Dose dependent effect of resveratrol in preventing cisplatin-induced ovarian damage in rats: An experimental study.The effects of prolonged fasting on the levels of adiponectin, leptin, apelin, and omentin in pregnant women.Can serum estradiol levels on the fourth day of IVF/ICSI cycle predict outcome in poor responder women?N terminal-pro brain natriuretic peptide in fetal umbilical cord meconium-stained amniotic fluid: a prospective case control study.Evaluation of cardiovascular disease risk in women with surgically induced menopause.The Value of Prostate-Specific Antigen in Diagnosis of Polycystic Ovarian Syndrome in Adolescent Girls.Sirtuin 1 Levels in Recurrent Implantation Failure.Serum sirtuin 1 levels in patients with polycystic ovary syndrome.Effect of postpartum counseling on postpartum contraceptive use.Effects of repeated propranolol administration in a rat model of surgically induced endometriosis.Maternal second trimester blood levels of selected heavy metals in pregnancies complicated with neural tube defects.Hyperemesis gravidarum is associated with increased maternal serum ischemia-modified albumin.Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?Tension-free vaginal tape compared with laparoscopic Burch urethropexy.Is there association between vitamin D levels, apelin 36, and visfatin in PCOS?Maternal mortality due to hemorrhage: population-based study in TurkeyAssessment of circulating betatrophin levels in intrahepatic cholestasis of pregnancyPregnancy-associated plasma protein a levels are decreased in obstetric cholestasisObstetric Outcomes among Syrian Refugees: A Comparative Study at a Tertiary Care Maternity Hospital in Turkey
P50
Q33743081-FC87CB43-10BD-4867-8636-69784C38232AQ33994926-B10A8E26-C428-4FBD-BA81-8701A864E31AQ34330425-45704710-EDBC-4C81-90E3-A1B630D9519EQ35675790-E8A1907D-1828-4458-A6D7-6257A8D57C2CQ36033454-F356C6C4-AC90-458B-894B-E17263346BF4Q37242858-FFED5A70-78A7-4AE3-882F-9E645EC6FAA3Q37512531-471EC113-32D5-403B-88CE-AA78D91D61DFQ37591843-58289CF7-4C29-4C9F-9789-DED4E4EE4B85Q37661233-3189ED42-5F84-434C-8740-4F31D8FA1819Q37731648-BD21052E-3056-4BBF-BBF2-5F0C05479620Q37853483-E92ADA64-185F-49E4-8828-CF9E794D4D39Q39456368-7174FE49-CB1C-4307-BBFD-F698A9ED81E2Q40559946-645AFAF3-6975-4597-BFAC-D9E92262B7C9Q44807382-9137CA55-57DA-4EB2-8A90-593AADB2925DQ45035182-89DF2810-91FF-40A0-A6B7-B0FEFCB8F253Q46082960-C57D24F4-4798-4243-AF9A-F1EEC985CD99Q46305898-636FE5E3-66BA-4222-8C59-7C69FF174DB0Q46515784-1D16BBD9-02D5-4366-A04D-DF2CB3CA9064Q46552045-640B70A5-571E-4F92-8EB4-590328E48B02Q46944654-6556A8F1-B6FD-45F2-B03B-54F72F8A8E07Q47138675-77EE0901-3838-4852-A3BF-7040BC92ECFFQ47695372-20547458-68B3-4879-8FA6-6F7990AE5F06Q47858474-0ADBDA9A-A045-4850-AFCA-215061BD3BCEQ48585566-35AC5928-50CA-45CE-974F-147DDEDC3AD1Q48663736-9AE6180E-A412-4656-AFAC-FAA3F8D7583BQ48955313-2AA273EF-1C74-4FEC-B11B-01F3E35114E8Q49834948-C479F4AE-360E-4F21-9863-B95E4DB29954Q50235329-F1252E88-F5D3-4DDC-B77C-9BFBA1994EB6Q51068064-31EE06A0-5225-4FC6-A43A-4F36C56FBAB8Q51099437-B9D72874-9BFE-4082-9921-569609455E0AQ51107940-D3B3BD7C-8A1A-48DF-9C20-6C002DB7763AQ51246690-FA945D91-8EF4-4C20-961E-FB651EA39939Q51281013-F67BA4CB-59A0-40DE-A300-84AEB8C2456EQ51496186-C9D56FD8-50E4-47F8-B72B-81B8969EC5F9Q51810122-CFAFBBC5-2042-427D-AFFF-3B43A84F5448Q53802680-F42AB417-6B1F-492D-B86C-95E4B50FE0E2Q56669868-E163D631-3370-461C-B83E-F99DB3D4069AQ57117433-3F5AA0BA-12FD-4EBD-9218-46007A7AF242Q57147421-78BCA6D6-3B2D-430C-BEC4-E49D2FE692D3Q57282061-A02270FD-78B1-44D7-9151-2632963DD315
P50
description
Turks onderzoekster
@nl
hulumtuese
@sq
researcher
@en
հետազոտող
@hy
name
Yaprak Engin-Ustun
@ast
Yaprak Engin-Ustun
@nl
Yaprak Engin-Üstün
@en
Yaprak Engin-Üstün
@es
Yaprak Engin-Üstün
@pt
Yaprak Engin-Üstün
@tr
type
label
Yaprak Engin-Ustun
@ast
Yaprak Engin-Ustun
@nl
Yaprak Engin-Üstün
@en
Yaprak Engin-Üstün
@es
Yaprak Engin-Üstün
@pt
Yaprak Engin-Üstün
@tr
altLabel
Yaprak Engin-Ustun
@en
prefLabel
Yaprak Engin-Ustun
@ast
Yaprak Engin-Ustun
@nl
Yaprak Engin-Üstün
@en
Yaprak Engin-Üstün
@es
Yaprak Engin-Üstün
@pt
Yaprak Engin-Üstün
@tr
P106
P1153
55893807400
P21
P27
P31
P496
0000-0002-1011-3848